NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live MediWound Ltd. Share Price Chart

O H L

MediWound Ltd. Performance Overview

Days Range
$13.27Low
$13.27High

Markets Today

Previous Close$13.35
Open$13.27
Volume44,316
Day's Range$13.27 - $13.27
52W Range$12.52 - $20.03
Market Cap$170.67 M

Historical Performance

1M Returns-2.13
3M Returns-6.25
6M Returns-21.47
1Y Returns-22.61
5Y Returns-46.43
10Y Returns-74.26

MediWound Ltd. Fundamentals

Market Cap$170.67 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$16.96 M
ROE TTM-0.64
EPS TTM$-1.60
Quarterly Earnings Growth YOYN/A
PB Ratio4.79
EBITDA$-23.41 M
Profit Margin-140.80
Market Cap$170.67 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$16.96 M
ROE TTM-0.64
EPS TTM$-1.60
Quarterly Earnings Growth YOYN/A
PB Ratio4.79
EBITDA$-23.41 M
Profit Margin-140.80

MediWound Ltd. Profit & Loss

Jun 2014Sep 2014Dec 2014Mar 2015Sep 2015Dec 2015
Total Revenue +$39.00 K$46.00 K$124.00 K$67.00 K$102.00 K$267.00 K
Gross Profit +-$684.00 K-$704.00 K-$1.02 M-$108.00 K-$722.00 K-$422.00 K
Operating Income -$5.15 M-$5.22 M-$6.59 M-$4.47 M-$4.36 M-$6.83 M
EBITDA -$5.01 M-$5.07 M-$6.59 M-$4.35 M-$4.24 M-$6.83 M
Interest Expense -$936.00 K-$532.00 K-$562.00 K-$1.60 M-$344.00 K-$415.00 K
Depreciation $137.00 K$150.00 K$0$115.00 K$120.00 K$0
Income Before Tax -$6.03 M-$5.02 M-$7.09 M-$5.99 M-$3.77 M-$7.78 M
Income Tax Expense N/AN/AN/AN/AN/AN/A
Net Income +-$6.01 M-$5.02 M-$7.09 M-$6.41 M-$3.77 M-$7.78 M
Net Profit Margin -15423.08%-10906.52%-5720.97%-9567.16%-3692.16%-2913.86%

MediWound Ltd. Financials Balance Sheet In USD

Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Share Capital $75.00 K$75.00 K$143.00 K$184.00 K$215.00 K$258.00 K
Reserve & Surplus -$134.96 M-$148.51 M-$168.11 M-$174.82 M-$205.05 M-$228.93 M
Non-Current Liabilities $15.53 M$13.61 M$27.05 M$16.74 M$15.80 M$16.91 M
Current Liabilities $8.27 M$10.72 M$12.06 M$18.13 M$26.54 M$25.71 M
Total Liabilities $23.80 M$24.33 M$39.10 M$34.86 M$42.34 M$42.62 M
Fixed Assets $2.99 M$2.77 M$2.60 M$9.39 M$14.23 M$18.67 M
Current Assets $26.19 M$14.95 M$45.84 M$49.70 M$52.16 M$59.96 M
Total Assets $31.07 M$19.74 M$50.02 M$66.46 M$73.50 M$86.25 M

MediWound Ltd. Cash Flow

Jun 2014Sep 2014Dec 2014Mar 2015Sep 2015Dec 2015
Net Income -$6.01 M-$5.02 M-$7.09 M-$6.41 M-$3.77 M-$7.78 M
Operating Cash Flow -$4.53 M-$4.35 M-$4.38 M-$4.77 M-$5.26 M-$4.89 M
Investing Cash Flow -$52.95 M$2.56 M$10.80 M-$2.95 M$16.00 M$22.08 M
Financing Cash Flow -$2.24 M$252.00 K$164.00 KN/A$40.00 K$643.00 K
Change in Cash -$59.77 M-$1.88 M$6.58 M-$8.32 M$10.78 M$17.84 M

MediWound Ltd. Return Calculator

The MediWound Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5,333
Invested Amount$10,000
Est. Returns$-4,667
Invest in USA Stock Today

About MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

FAQs

MediWound Ltd. (MDWD) share price as of September 18, 2026 is $13.29. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the MediWound Ltd. (MDWD) Share by opening an international trading account with Angel One.
Purchasing MediWound Ltd. (MDWD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying MediWound Ltd. (MDWD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of MediWound Ltd. (MDWD) or any other US company shares in Angel One for any dollar amount.
The market capitalization of MediWound Ltd. on September 18, 2026, is $170.67 M.
MediWound Ltd. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in MediWound Ltd. (MDWD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91